Aveanna Healthcare (AVAH) CEO logs tax-related open-market share sales

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Chief Executive Officer Jeff Shaner reported tax-related stock sales. Over February 17–19, 2026, he sold a total of 461,909 shares of common stock in open-market transactions at weighted average prices between about $7.06 and $7.97. According to the footnotes, these sales were automatically executed by the company’s stock plan administrator to cover his tax obligations arising from vested equity awards. After these sales, Shaner directly held 2,650,892 shares of Aveanna common stock.

Insights

Equity compensation and governance analyst

CEO’s reported stock sales are tied to tax withholding on vested awards.

The transactions show Jeff Shaner, CEO of Aveanna Healthcare Holdings, selling a total of 461,909 common shares between February 17–19, 2026. Each is coded as an open-market sale, but the footnotes state they were executed to satisfy tax obligations from vested equity awards.

Because the sales were automatic and administered under the company’s stock plan, they resemble tax-withholding events rather than discretionary selling. After these trades, Shaner still directly owns 2,650,892 shares, so he retains a substantial equity position. The filing does not indicate any change to company operations or financial outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaner Jeff

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/17/2026		S(1)		119,884	D	$7.6451(2)	2,992,917	D
Common Stock, par value $0.01 per share	02/18/2026		S(1)		168,800	D	$7.3829(3)	2,824,117	D
Common Stock, par value $0.01 per share	02/19/2026		S(1)		173,225	D	$7.2082(4)	2,650,892	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.

2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Aveanna (AVAH) shares did CEO Jeff Shaner sell in this Form 4?

Jeff Shaner reported selling 461,909 shares of Aveanna common stock. The sales occurred over February 17–19, 2026 in open-market transactions and were executed by the stock plan administrator primarily to cover tax obligations tied to vested equity awards.

On what dates did Aveanna CEO Jeff Shaner’s reported stock sales occur?

The reported sales took place on February 17, 18 and 19, 2026. Each transaction involved Aveanna common stock sold in the open market at weighted average prices ranging from about $7.06 to $7.97, according to the Form 4 transaction details and footnotes.

Why were Jeff Shaner’s Aveanna (AVAH) stock sales executed, according to the filing?

The filing explains that the shares were automatically sold to satisfy Jeff Shaner’s tax obligations on equity awards that had vested. The company’s stock plan administrator handled these aggregate sales, rather than discretionary trading decisions by Shaner in the open market.

How many Aveanna shares does CEO Jeff Shaner hold after these transactions?

After the reported sales, Jeff Shaner directly holds 2,650,892 shares of Aveanna common stock. This post-transaction holding is disclosed in the Form 4 data, indicating he maintains a significant equity stake in the company following the tax-related share disposals.

What prices were received for the Aveanna (AVAH) shares sold in this Form 4?

The filing lists weighted average sale prices for each trade line. Reported averages include about $7.6451, $7.3829, and $7.2082 per share, with detailed price ranges from roughly $7.06 up to $7.97 for the individual sale transactions encompassed.

Were Jeff Shaner’s Aveanna stock sales handled directly by him or by a plan administrator?

The Form 4 footnotes state that the transactions were part of aggregate sales by the company’s stock plan administrator. These automatic sales were made to cover tax liabilities on vested equity awards, rather than discretionary open-market trading directed personally by Jeff Shaner.